Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,171 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Regional differences in the characteristics and treatment of patients participating in an international heart failure trial. The Assessment of Treatment with Lisinopril and Survival (ATLAS) Trial Investigators.
Massie BM, Cleland JG, Armstrong PW, Horowitz JD, Packer M, Poole-Wilson PA, Ryden L. Massie BM, et al. Among authors: cleland jg. J Card Fail. 1998 Mar;4(1):3-8. doi: 10.1016/s1071-9164(98)90502-4. J Card Fail. 1998. PMID: 9573498 Free article. Clinical Trial.
Is the prognosis of heart failure improving?
Cleland JG, Gemmell I, Khand A, Boddy A. Cleland JG, et al. Eur J Heart Fail. 1999 Aug;1(3):229-41. doi: 10.1016/s1388-9842(99)00032-x. Eur J Heart Fail. 1999. PMID: 10935669 Free article.
Sudden death in heart failure: vascular or electrical?
Cleland JG, Massie BM, Packer M. Cleland JG, et al. Eur J Heart Fail. 1999 Mar;1(1):41-5. doi: 10.1016/S1388-9842(99)00009-4. Eur J Heart Fail. 1999. PMID: 10937978 Free article. No abstract available.
Low doses vs. high doses of the angiotensin converting-enzyme inhibitor lisinopril in chronic heart failure: a cost-effectiveness analysis based on the Assessment of Treatment with Lisinopril and Survival (ATLAS) study. The ATLAS Study Group.
Sculpher MJ, Poole L, Cleland J, Drummond M, Armstrong PW, Horowitz JD, Massie BM, Poole-Wilson PA, Ryden L. Sculpher MJ, et al. Eur J Heart Fail. 2000 Dec;2(4):447-54. doi: 10.1016/s1388-9842(00)00122-7. Eur J Heart Fail. 2000. PMID: 11113723 Free article. Clinical Trial.
Toleration of high doses of angiotensin-converting enzyme inhibitors in patients with chronic heart failure: results from the ATLAS trial. The Assessment of Treatment with Lisinopril and Survival.
Massie BM, Armstrong PW, Cleland JG, Horowitz JD, Packer M, Poole-Wilson PA, Rydén L. Massie BM, et al. Among authors: cleland jg. Arch Intern Med. 2001 Jan 22;161(2):165-71. doi: 10.1001/archinte.161.2.165. Arch Intern Med. 2001. PMID: 11176729 Clinical Trial.
1,171 results